1 / 35

The Call (a brief tour of breast cancer)

The Call (a brief tour of breast cancer). Family Medicine Review Course 2011 Christian Cable, MD, FACP. The Case. Could the mammogram be wrong?. BI-RADS. 0: Incomplete 1: Negative 2: Benign finding(s) 3: Probably benign 4: Suspicious abnormality

adam-kirkland
Télécharger la présentation

The Call (a brief tour of breast cancer)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Call(a brief tour of breast cancer) Family Medicine Review Course 2011 Christian Cable, MD, FACP

  2. The Case

  3. Could the mammogram be wrong?

  4. BI-RADS 0: Incomplete 1: Negative 2: Benign finding(s) 3: Probably benign 4: Suspicious abnormality 5: Highly suggestive of malignancy 6: Known biopsy – proven malignancy

  5. What will happen with the biopsy?

  6. What will be learned from the biopsy?

  7. Invasive ductal CA confirmed • Estrogen Receptor • Progesterone Receptor • HER-2 Expression • Histologic grade

  8. If it is breast cancer, then what?

  9. Surgery: primary, reconstructive • Medical Oncology: adjuvant therapy • Radiation Oncology: allows breast conservation

  10. What are the surgical options?

  11. What will be learned from surgery?

  12. When will I see a medical oncologist?

  13. What is adjuvant therapy? • anti-estrogen pills (tamoxifen, anastrazole) • chemotherapy • trastuzamab (monoclonal ab to HER2)

  14. How will I know if I need it?

  15. ER+, LN- • Low recurrence score: 50% • High recurrence score: 25% • Intermediate recurrence score: 25%

  16. Adjuvant Therapy

  17. Side effects? • anti-estrogen pills (tamoxifen, anastrazole) • chemotherapy • trastuzamab (monoclonal ab to HER2)

  18. How much good will it do?(absolute survival benefit at 15 yrs) • tamoxifen: 9% • chemo (women under 50): 10% • chemo (women 50-59): 3%

  19. What about radiation?

  20. Allows Breast Conservation • whole breast (traditional) • partial breast

  21. Survivorship

More Related